Page 183 - CW E-Magazine (21-11-2023)

Document

cost compared to more efficient eco- infrastructure that integrates modern logistics to promote efficiency
nomies. supply chains. Under the Atal Innova- across the supply chain and sup-
tion Mission, Government is setting ported by IT enabled systems in-
In the present context, Government up Atal Incubation Centres (AICs), in cluding AI/ML.
of India’s thrust for creation of world- the public and private sectors, as well
class infra facilities at three Bulk Drug as scaling up Established Incubation This policy recognises that an effi-
Parks and four Medical Devices Parks Centres (EICs). A number of start-up cient and robust logistics framework is
across the country mark a sound begin- incubators are already functioning in life indispensable for the seamless distri-
ning in enhancing infrastructure and sciences, biotech, medical devices and bution of pharmaceuticals and medical
strengthening logistics. Further, various MedTech space under ‘Start up India’. supplies. By investing in cutting-edge
other States too are seen to take initi- However, the current infrastructure technologies and streamlining supply
ative in this regard. is limited and concentrated in a few chains, the policy aims to minimise
nascent innovation hubs in the country, transit times, reduce wastage, and
The Pharma industry would fur- emphasising the need for more high- enhance the overall efficacy of health-
ther benefit from a focus to reduce the quality infrastructure. Measures will care delivery.
turnaround time (TAT) and upgrade the be explored for strengthening the in-
capacity and capability of the logistics frastructure for innovation in pharma Leveraging digital transformation:
network in India, including creation of medtech sectors in India, including The policy is expected to provide
Logistics Parks and creation of dedi- scaling up, creating sub-sector specific the required support and directions to
cated corridors connecting important hubs, integrating Centres of Excellence strengthen the pharma ecosystem by
pharma hubs. Emphasis on increasing with Innovation hubs. leveraging digital capabilities across
the digitalisation and automation can various aspects into a competitive, self-
substantially reduce time and errors. Other areas of the policy would reliant, resilient and innovative in-
Scaling up road infrastructure will lead include: dustry. This policy acknowledges the
to significant optimisation in carry capa- Strengthen domestic testing and potential of digital technologies, such as
city. Specifically, for the pharma sec- certification facilities to ensure telemedicine, electronic health records,
tor, there is a need to enable faster high-quality and safe pharmaceuti- and data analytics, to revolutionise
clearance of temperature-sensitive cals. healthcare delivery and pharma in-
items while maintaining the tempera- Upgradation of Indian industry’s novation. By harnessing the power of
ture monitoring at the desired levels infrastructure to include World AI, ML, and blockchain, it aims to bolster
throughout the supply chain. Health Organisation (WHO)-Good drug safety, supply chain management,
Manufacturing Practices (GMP) and regulatory compliance.
In the context of learning from standards so as to enable them to
COVID19 pandemic and growing bio- participate and compete in global In the knowledge economy, the exist-
pharma sector, it is imperative to up- markets. ing mindset has to change from a “siloed
grade the cold chain capacity and capa- Encourage the establishment of approach towards health data” to a new
bility in the country to ensure quicker Bulk Drug Parks and enhance vision of “convergence of drugs, de-
availability of vaccines, biopharma MSME clusters. vices, and data”. The current disparate
and health commodities and cater not Efforts to digitise available capa- health data systems, medicines and

to just domestic demand, but global cities of storage region-wise shall devices, which create inefficiencies in
demand in a competitive manner and with facilitate real-time decision mak- multi-stakeholder processes and in-
seamless integration with global supply ing and efficient operations. The teractions, will have to be streamlined
chains. Towards this, the policy seeks to National Industrial Corridor shall with significant savings and effici-
effectively leverage the PM-Gati Shakti complement creation of centres of encies for patients, manufacturers, and
National Master Plan Portal in meeting manufacturing excellence with inte- service providers.
the various demands of the industry. grated facilities to enable companies Invigorate innovations by enabling

to leverage India’s competitiveness human capabilities & digital tech-
NPP 2023 aims to enhance research in the value chain and increase nologies.
infrastructure where the priority will be India’s manufacturing prowess Leverage data to increase the effi-

to augment existing infrastructure and beyond generics. ciency and efficacy of drug develop-
build a new generation of world-class Optimise end-to-end transport ment, production, and distribution.

Chemical Weekly November 21, 2023 183

Contents Index to Advertisers Index to Products Advertised